Comparative Pharmacology
Head-to-head clinical analysis: CORTEF versus PREDAIR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CORTEF versus PREDAIR.
CORTEF vs PREDAIR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Corticosteroid that binds to the glucocorticoid receptor, leading to altered gene expression and inhibition of inflammatory mediators such as prostaglandins and leukotrienes.
Prednisone is a prodrug that is converted to prednisolone, which binds to the glucocorticoid receptor, leading to anti-inflammatory and immunosuppressive effects via modulation of gene expression.
Hydrocortisone (Cortef) 10-30 mg orally 2-4 times daily; for anti-inflammatory effect: 20-240 mg orally daily in divided doses; for physiologic replacement: 20-30 mg orally daily in divided doses (e.g., 10 mg morning, 5 mg afternoon).
10-60 mg orally once daily in the morning, gradually tapered as tolerated. Maintenance dose 5-10 mg orally once daily.
None Documented
None Documented
Plasma terminal half-life: 1.5–2.5 hours (cortisol); duration of action: 8–12 hours due to intracellular effects.
3-4 hours (terminal) in patients with normal renal function; prolonged to 12-24 hours in severe renal impairment (CrCl <30 mL/min).
Renal (primarily as inactive metabolites, <5% unchanged); biliary/fecal (minor).
Renal: 75-90% as unchanged drug; Biliary/Fecal: 10-25% as metabolites and unchanged drug.
Category C
Category C
Systemic Corticosteroid
Systemic Corticosteroid